Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02586896 · ClinicalTrials.gov registry record · NA
Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments
A NA study of Opioid Dependence, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT02586896: Completed NA study of Opioid Dependence, sponsored by NYU Langone Health.
NCT02586896 is a NA study of Opioid Dependence that has completed, run by NYU Langone Health. The registered enrollment target is 300 participants, above the 148-participant average among 29 other Opioid Dependence trials with a reported enrollment target (103% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02586896, a NA study of Opioid Dependence, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the effects of brief strengths-based case management (SBCM) to the effects of screening, assessment and referral alone (SAR) in opioid-dependent patients. Participants meeting DSM-IV criteria for opioid dependence will be randomly assigned (150 per group) to receive 1) up to 6 sessions of SBCM; or 2) SAR. Follow-up assessments will be completed at 3 and 6 months, by staff who are blinded to treatment condition.
Primary Outcome
"Initiation" is defined as a dichotomous outcome (yes/no), and is considered to have occurred if patients report any substance abuse counseling sessions (excluding SBCM) from the time of the baseline assessment up to the day before the three-month interview, as captured via self-report on the Form 90-D.
Conditions Studied
Interventions
- BEHAVIORAL Strengths-based Case Management (SBCM)
- BEHAVIORAL Screening, Assessment, and Referral (SAR)
Study Locations (1)
New York
- Bellevue Hospital Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-04-23 |
| Phase | NA |
What the finished NCT02586896 record still lists
NCT02586896 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 148-participant average among 29 other Opioid Dependence trials with a reported enrollment target (103% higher).
The record links to 1 condition, with Opioid Dependence appearing as the primary indexed condition, and to 2 interventions - of which Strengths-based Case Management (SBCM) is the first listed.
NCT02586896 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02586896 about?
NCT02586896 is a clinical study titled "Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments". This study will compare the effects of brief strengths-based case management (SBCM) to the effects of screening, assessment and referral alone (SAR) in opioid-dependent patients. Participants meeting DSM-IV criteria for opioid dependence will be randomly assigned (150 per group) to receive 1) up to ...
What is the current status of trial NCT02586896?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2016-03. Estimated completion is 2019-04-23.
What conditions does trial NCT02586896 study?
This clinical trial studies the following conditions: Opioid Dependence.
What interventions are being tested in trial NCT02586896?
The interventions under investigation include: Strengths-based Case Management (SBCM) (BEHAVIORAL), Screening, Assessment, and Referral (SAR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02586896?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02586896 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02586896's enrollment target sits among peer trials
300 5th of 29 higher than 25 of 29 other Opioid Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
RECRUITING · NA
-
Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder
ACTIVE NOT RECRUITING · NA
-
Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II
COMPLETED · NA
-
fMRI and Opioid Abstinence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia